Locations:
Search IconSearch

Hematology & oncology

IV fluids

Study Supports Single-Dose Rasburicase for Tumor Lysis Syndrome

Findings suggest that a uniform dose can be an effective preventive strategy

21-CHP-2079183_650x450

Screening for and Managing Pulmonary Dysfunction in Pediatric Cancer Survivors

Cleveland Clinic experts discuss current guidelines and new research

mother and daughter on pediatric oncology ward
May 3, 2021/Cancer

Investigation of Childhood Cancer Predisposition Syndromes

Searching for new causes of familial cancer

Chemo
April 6, 2021/Cancer

Pediatric-Inspired Regimen Well Tolerated by Adolescents and Young Adults With Acute Lymphoblastic Leukemia

A deep dive into survival differences between pediatric and adolescent/young adult leukemia patients

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Genetic testing
January 27, 2021/Cancer

Integrating Medical Genetics Into the Care of Pediatric Oncology Patients

5 scenarios in which you should consider cancer predisposition

Zebrafish embryo
December 31, 2020/Cancer

Zebrafish Models Fuel Study of Pediatric Neutropenias

Unique model is an excellent genetic animal model for study of lethal diseases

650×450-ERM-Novel-Therapy

Potential Novel Therapeutic Strategy in Rhabdomyosarcoma Based on Ezrin-Radixin-Moesin Inhibition

Preclinical studies point to antitumor activity of the ERM inhibitor NSC668394

Rabi Hanna, MD
September 17, 2020/Cancer

Individualizing Therapy for Cancer Patients With Autism Spectrum Disorder

Simple adjustments can make a significant difference

BackPage 5 of 6Next

Advertisement

Ad